| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| isis-crp | tyrosine-protein kinase abl1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Inflammation[MeSHID:D007249] |
NA | phase 1 | unknown |
| isis-crp | crp messenger rna | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Inflammation[MeSHID:D007249] |
NA | phase 1 | unknown |
| isis-crp | lck tyrosine protein kinase | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Inflammation[MeSHID:D007249] |
NA | phase 1 | unknown |
| isis-crp | tyrosine-protein kinase brk | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Inflammation[MeSHID:D007249] |
NA | phase 1 | unknown |
| isis-crp | rip2 messenger rna | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Inflammation[MeSHID:D007249] |
NA | phase 1 | unknown |
| isis-crp | proto-oncogene c-src | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Inflammation[MeSHID:D007249] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||